scholarly journals Assessment of anti-depressant activity of omega 3 fatty acids in rodents

2018 ◽  
Vol 7 (12) ◽  
pp. 2353
Author(s):  
Arshaduddin Ahmed Syed ◽  
Kamathi Vipin Chandra
Keyword(s):  
Fatty Acids ◽  
Forced Swim Test ◽  
Antidepressant Effect ◽  
Control Group ◽  
Standard Group ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Swim Test ◽  
Forced Swim ◽  
Significant Difference

Background: Depression contributes to significant disease burden at national and global levels. At the personal and domestic level too, depression leads to poor quality of life, causing a huge socioeconomic impact. In the world, over 300 million people are estimated to have depression and the numbers of depressed persons are only projected to go up.Methods: The forced swim test (FST) is one of the most commonly used animal models for assessment of antidepressant effects in rodents. In the modified version of this test, the rats are forced to swim in a glass tank with no means of escape, inducing a behaviour of immobility, which resembles a state of despair, akin to depression in humans. The rats were divided into 6 groups: 1. control group: treated with distilled water; 2. standard group treated with fluoxetine Hcl (10mg/kg); 3.test-1 group treated with omega-3 FAs (300mg/kg); 4.test-2 group treated with a higher dose of omega-3 FAs (500 mg/kg); 5.test-3 group treated with omega-3 FAs (300mg/kg) and fluoxetine (10mg/kg); and 6.test-4 group treated with omega-3 FAs (500 mg/kg) and fluoxetine (10mg/kg).Results: The independent between-groups ANOVA yielded a statistically highly significant result, F (5, 30) = 9.47, P <0.001. Thus, the null hypothesis of no difference between the means was rejected. To further evaluate the nature of the differences between the means of the six groups, the statically significant ANOVA result was followed by Tukey's honest significant difference post-hoc tests.Conclusions: This study finds that omega 3 fatty acids have intrinsic antidepressant activity, and the combination of fluoxetine and omega 3 fatty acids has significantly more antidepressant effect than fluoxetine alone in the forced swim test done on Wistar rats.

scholarly journals The Effect of Administration of Omega-3 and Vitamin E on the Levels of Reactive Oxygen Species (ROS) and Nitric Oxide (NO) in Preeclampsia White Rats (Rattus Norvegicus)

2021 ◽  
Vol 8 (12) ◽  
pp. 7-15
Author(s):  
Dina Taufia ◽  
Syamel Muhammad ◽  
Arni Amir
Keyword(s):  
Oxidative Stress ◽  
Fatty Acids ◽  
Vitamin E ◽  
Control Group ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Pregnant Rats ◽  
White Rats ◽  
Significant Difference ◽  
One Way Anova

Background: Preeclampsia is a disease with a variety of theories that describe the uncertainty of the pathophysiology. According to the oxidative stress theory, preeclampsia originates from the failure of trophoblast invasion during the implantation process, causing ischemia and placental hypoxia, which in turn causes cell damage, including placental endothelial cell dysfunction. Omega-3 fatty acids and vitamin E have an important role in preventing preeclampsia. Omega-3 fatty acids play an important role in maintaining cell membranes and anti-inflammatory processes. At the same time, vitamin E acts as a fat-soluble antioxidant that can prevent oxidative stress, inhibit proinflammatory cytokines, and protect fatty acids from oxidation. Aim: The purpose of this study was to determine the effect of omega-3 and vitamin E on the level of ROS and NO in pregnant rats with preeclampsia models. Method & Material: This type of research is experimental with Post-Test Only Control Group Design. The sample consisted of 35 pregnant rats, which were divided into five groups. On the 19th day, blood serum was taken to check the levels of ROS and NO. The measuring instrument used is a spectrophotometer with the ELISA method. Data were analyzed using the Shapiro Wilks normality test. After the parametric test was completed, the hypothesis was tested using one-way ANOVA. Results: The average levels of ROS in each group were K- : 121,684 ng/L, K+ : 143,885 ng/L, P1 : 136,250 ng/L, P2 : 132.433 ng/L, and P3 : 122,993 ng/L. The average levels of NO obtained were K-: 29,502 ng/L, K+: 26,053 ng/L, P1: 27,250 ng/L, P2: 27,555 ng/L, and P3: 32,278 ng/L. The results of one-way ANOVA analysis showed that the administration of omega-3 and vitamin E had a significant difference between the control and treatment groups, both at levels of ROS (p=0.001) and levels of NO (p=0.001). Conclusion: The administration of omega-3, vitamin E, and omega-3 plus vitamin E can reduce ROS levels in pregnant rats with preeclampsia models. There is an increase of NO levels only in the administration of omega-3 plus vitamin E. Keywords: [Omega-3, Vitamin E, Oxidative stress, ROS, NO, Preeclampsia].

scholarly journals Antidepressant effects of Mentha pulegium in mice

2016 ◽  
Vol 11 (3) ◽  
pp. 711 ◽  
Author(s):  
Zahra Rabiei ◽  
Mostafa Gholami ◽  
Mahmoud Rafieian-Kopaei
Keyword(s):  
Essential Oil ◽  
Forced Swim Test ◽  
Video Clip ◽  
Antidepressant Effect ◽  
Control Group ◽  
Mentha Pulegium ◽  
Swim Test ◽  
Forced Swim ◽  
Antidepressant Effects ◽  
Nitrite Content

<p class="Abstract">The aim of this study is to investigate the antidepressant effects of <em>Mentha pulegium</em> essential oil in BALB/c mice. Six experimental groups (7 mice each) were used. Forced swim test was performed 30 min after essential oil injection. In the groups receiving <em>M. pulegium</em> essential oil (50, 75 and 100 mg/kg), immobility duration significantly decreased compared to the control group. <em>M. pulegium</em> (50 and 75 mg/kg) resulted in significant decrease in nitrate/nitrite content in serum compared to the control group. <em>M. pulegium</em> essential oil antidepressant effect that may be due to the inhibition of oxidative stress.  The results showed that decrease in nitrate/nitrite content in serum and high anti-oxidant effects of M. pulegium essential oil.</p><p><strong>Video clip:</strong></p><p><a href="https://youtube.com/v/qfmjCf5FNMk">Immobility in Forced Swim Test</a>: 13 sec</p><p><a href="https://youtube.com/v/oqWS13JzQtQ">Mobility in Forced Swim Test</a>: 19 sec</p><p> </p><p> </p>

scholarly journals Evaluation of antidepressant activity of tramadol in comparison with imipramine in Swiss albino mice

2017 ◽  
Vol 6 (3) ◽  
pp. 695
Author(s):  
Chiranjeevi Bonda ◽  
Sudhir Pawar ◽  
Jaisen Lokhande
Keyword(s):  
Forced Swim Test ◽  
Antidepressant Activity ◽  
Tail Suspension Test ◽  
Antidepressant Effect ◽  
Tail Suspension ◽  
Swim Test ◽  
Forced Swim ◽  
Group I ◽  
Immobility Time ◽  
Suspension Test

Background: The aim of the study was to evaluate the antidepressant effect of opioid analgesic tramadol using forced swim test and tail suspension test models.Methods: The antidepressant effect was assessed by recording the immobility time in Forced swim test (FST) and Tail suspension test (TST). The mice were randomly divided into five groups. Mice belonging to group I was given normal saline (0.1ml/kg) which acted as control. Group II received imipramine (15mg/kg) considered as the standard drug tramadol was given in graded dose (10, 20 and 40 mg/kg) to mice of groups III, IV, V respectively. All drugs were administered intraperitoneally for seven successive days; test was done on 7th day.Results: Tramadol and Imipramine showed antidepressant activity when compared to control. There is dose dependent increase in antidepressant activity of tramadol. The antidepressant activity of imipramine was significantly (P<0.05) more than tramadol at dose 10 and 20 mg/kg but antidepressant activity with tramadol 40mg/kg was comparable to imipramine treated mice.Conclusions: The results of this study indicated the presence of antidepressant activity of tramadol at 40mg/kg.

scholarly journals Pharmacological Evaluation of Antidepressant-Like Effect of Genistein and Its Combination with Amitriptyline: An Acute and Chronic Study

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Gaurav Gupta ◽  
Tay Jia Jia ◽  
Lim Yee Woon ◽  
Dinesh Kumar Chellappan ◽  
Mayuren Candasamy ◽  
...  
Keyword(s):  
Synergistic Effects ◽  
Standard Dose ◽  
Forced Swim Test ◽  
Tail Suspension Test ◽  
Antidepressant Effect ◽  
Control Group ◽  
Treatment Groups ◽  
Swim Test ◽  
Immobility Time ◽  
Chronic Study

The present study was designed to evaluate the acute and chronic antidepressant effect of genistein in combination with amitriptyline in mice. Animals were divided into six groups (n=6) for treatment with water, genistein, or amitriptyline, either alone or in combination for ten days. Animals were subjected to locomotor activity testing; tail suspension test (TST); and forced swim test (FST) and immobility time was recorded on day one and day ten. Acute treatment of all treatment groups did not significantly reduce the immobility time (p>0.05). Chronic treatment of combination of genistein (10 mg/kg) and amitriptyline (5 mg/kg and 10 mg/kg) significantly reduced the immobility time as compared to control group (p<0.001) and was comparable to amitriptyline alone (10 mg/kg). However, no changes in anti-immobility activity in combination of subeffective doses of genistein (5 mg/kg) and amitriptyline (5 mg/kg) were observed. Genistein at its standard dose (10 mg/kg) rendered synergistic effects in combination with subeffective dose of amitriptyline (5 mg/kg) and additive effects in combination with therapeutic dose of amitriptyline (10 mg/kg).

scholarly journals Neonatal treatment with fluoxetine reduces depressive behavior induced by forced swim in adult rats

2002 ◽  
Vol 60 (4) ◽  
pp. 928-931 ◽  
Author(s):  
Cristiano Mendes-da-Silva ◽  
Sandra Lopes de Souza ◽  
Jairza Maria Barreto-Medeiros ◽  
Sebastião Rogério de Freitas-Silva ◽  
Daniela Eugênia Costa Antunes ◽  
...  
Keyword(s):  
Forced Swim Test ◽  
Experimental Models ◽  
Control Group ◽  
Adult Rats ◽  
Depressive Behavior ◽  
Swim Test ◽  
Serotonergic Activity ◽  
Forced Swim ◽  
Neonatal Administration ◽  
The Brain

Serotonin plays a role at the pathophysiology of depression in humans and in experimental models. The present study investigated the depressive behavior and the weigh evolution in adult rats (60 days) treated from the 1st to the 21st postnatal day with fluoxetine, a selective serotonin reuptake inhibitor (10 mg/kg, sc, daily). The depressive behavior was induced by the forced swim test (FST). The animals were submitted to two sessions of FST: 1st session for 15 min and the 2nd session 24h later, for 5 min. During the 2nd session the Latency of the Attempt of Escape (LAE) and Behavioral Immobility (BI) were appraised. The Fluoxetine group when compared to the Control group, showed an increase in LAE and a decrease in BI. The neonatal administration of fluoxetine reduced the depressive behavior in adult rats, possibly by increase in the brain serotonergic activity. This alteration can be associated to process of neuroadaptation.

A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e24115-e24115
Author(s):  
Zoneddy R. Dayao ◽  
Ursa Abigail Brown-Glaberman ◽  
V. Shane Pankratz ◽  
Lu Chen ◽  
Jacqueline M. Lafky ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Pain Score ◽  
Acute Pain ◽  
Pain Syndrome ◽  
Double Blind Study ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Significant Difference ◽  
Maximum Pain ◽  
To Receive

e24115 Background: Paclitaxel, a widely used chemotherapeutic agent, is associated with an acute pain syndrome (P-APS) and chronic chemotherapy-induced peripheral neuropathy (CIPN). Currently, there is no standard of care for P-APS. Commonly used analgesics, including NSAIDs and narcotics, have considerable toxicity profiles. Omega-3 fatty acids, a common dietary supplement, have well established anti-inflammatory and neuroprotective properties. The primary aim of the study was to assess if omega 3 fatty acids could prevent P-APS. Methods: Patients scheduled to receive weekly paclitaxel (70-90mg/m2) were randomized to receive 4 g of omega-3 acid ethyl esters (Lovaza) or placebo, beginning 1 week prior to starting paclitaxel and continued until paclitaxel was discontinued. Patients completed acute pain questionnaires at baseline, Days 2-7, prior to each subsequent treatment and one month after completion of therapy. The EORTC- QLQ CIPN 20 questionnaire was completed prior to each dose of paclitaxel and 1 month after completion. The primary objective was to compare the effect of omega 3 fatty acids, versus placebo, on the maximum pain score for the week following the 1st treatment and each subsequent paclitaxel treatment, and to compare pain medication use between the 2 arms. The secondary objective was to compare the effect of the intervention on the severity of CIPN. Results: 49 patients were randomized to treatment versus placebo. Linear mixed effects models were applied with the addition of a bootstrap approach to overcome limitations in the distributional assumptions to compare outcomes between treatment groups. Placebo results were similar to the reported natural history of P-APS. There was no significant difference in trends over time between the 2 groups in the maximum pain score at week 1 (p = .14) and over 12 weeks (p = .21). There was also no difference noted in the rates of use of over the counter analgesics (p = .39) and narcotics (p = .46). CIPN results did not differ between the 2 groups (p = .08). Conclusions: The results of this pilot study do not support the use of omega-3 fatty acids for the prevention of paclitaxel-associated pain syndrome. Clinical trial information: NCT01821833 .

scholarly journals Omega-3 polyunsaturated fatty acids-enriched hen eggs consumption enhances microvascular reactivity in young healthy individuals

2018 ◽  
Vol 43 (10) ◽  
pp. 988-995 ◽  
Author(s):  
Ana Stupin ◽  
Lidija Rasic ◽  
Anita Matic ◽  
Marko Stupin ◽  
Zlata Kralik ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Polyunsaturated Fatty Acids ◽  
Lipid Profile ◽  
Serum Lipid ◽  
Serum Lipid Profile ◽  
Control Group ◽  
Omega 3 ◽  
Healthy Individuals ◽  
Microvascular Reactivity ◽  
Significant Difference

The beneficial effect of omega-3 polyunsaturated fatty acids (PUFA) supplementation on the cardiovascular (CV) system is well supported in CV patients; however, the effect of the consumption of omega-3 PUFA-enriched functional food in healthy individuals is still not fully elucidated. This study aimed to determine the effect of the consumption of omega-3 PUFA-enriched hen eggs on the microvascular reactivity (primary outcome), blood pressure (BP), and serum lipid profile in young healthy individuals. The control group (N = 16) ate 3 ordinary hen eggs (277 mg of omega-3 PUFAs/day), and the OMEGA-3 group (N = 20) ate 3 omega-3 PUFA-enriched eggs containing 259 mg of omega-3 PUFAs/egg daily (α-linolenic acid (ALA), 167 mg/egg; eicosapentaenoic acid (EPA), 7 mg/egg; docosahexaenoic acid (DHA), 84 mg/egg) for 3 weeks (777 mg of omega-3 PUFA/day). Postocclusive reactive hyperemia (PORH) in skin microcirculation assessed by laser Doppler flowmetry, serum lipid profile, fasting blood glucose, high-sensitivity C-reactive protein (hsCRP), and arterial BP were measured in all subjects before and after the protocol. PORH was significantly enhanced, and triglycerides, hsCRP, and BP were significantly decreased in the OMEGA-3 group compared with baseline measurements, whereas there was no significant difference in the control group after the protocol when compared with baseline. To the best of our knowledge, this is the first study to demonstrate that consumption of a mixture of omega-3 PUFA (ALA + EPA + DHA), provided via enriched hen eggs, elicits changes in the microvascular reactivity, BP, and triglyceride level in healthy subjects that are associated with CV benefits, thus suggesting that daily consumption of omega-3 PUFA-enriched eggs in healthy individuals may potentially contribute to CV risk factor attenuation and disease prevention.

Sertraline treatment attenuates the sex differentiated behavioural stress response in the rat forced swim test

2011 ◽  
Vol 26 (S2) ◽  
pp. 802-802
Author(s):  
N. Kokras ◽  
C. Dalla ◽  
K. Antoniou ◽  
Z. Papadopoulou-Daifoti
Keyword(s):  
Sex Differences ◽  
Stress Response ◽  
Antidepressant Treatment ◽  
Forced Swim Test ◽  
Behavioural Response ◽  
Antidepressant Effect ◽  
Swim Test ◽  
Forced Swim ◽  
Female Wistar Rats ◽  
Climbing Behaviour

IntroductionSex differences have been described in depression and more recently in antidepressant response. Animal models and in particular the Forced Swim Test (FST), are widely used to investigate the behavioural response to stress and to antidepressant treatment.ObjectivesThe present study explored sex differences in the stress response during the FST and examined whether antidepressant treatment alleviates the sex-differentiated stress response.MethodsAdult male and female Wistar rats were subjected to a 15 min FST session and then treated with three injections of sertraline 10 mg/kg or vehicle at 0, 19 and 23 hours post-FST. Twenty-four hours after the first FST, they had a second 5 min FST session and their behaviour was recorded.ResultsVehicle-treated females exhibited 66% longer duration and 70% shorter latency of immobility than males, suggesting enhanced levels of despair. Sertraline did not significantly affect immobility, but exerted its antidepressant effect by elongating swimming duration in both sexes and shortening climbing behaviour in males only. In contrast, to vehicle-treated rats, no sex differences were observed in sertraline-treated rats in any of these behavioural parameters. However, sex-differences in head swinging behaviour, which is unaffected by sertraline treatment, were still observed in sertraline-treated rats.ConclusionsFemales appear more vulnerable than males to the FST, but the post-treatment organisation of FST behaviour is not sex-differentiated. Antidepressants seem to modulate the behavioural response in FST in a sex-specific way, due to sex differences in baseline FST performance. Consequently, the sex-differentiated stress response profile during FST is attenuated by antidepressant treatment.

scholarly journals Studying the adaptogenic activity of a series of tetrahydropyrido[2,1-b] [1,3,5] thiadiazine derivatives

2019 ◽  
Vol 18 (3) ◽  
pp. 21-28 ◽  
Author(s):  
E. Yu. Bibik ◽  
I. A. Nekrasa ◽  
A. V. Demenko ◽  
K. A. Frolov ◽  
V. V. Dotsenko ◽  
...  
Keyword(s):  
Forced Swim Test ◽  
Work Capacity ◽  
Modern World ◽  
Control Group ◽  
Physical Factors ◽  
Swim Test ◽  
Forced Swim ◽  
Group 5 ◽  
Adaptogenic Activity ◽  
Initial Results

Introduction. In the modern world people are exposed to the influence of adverse psychological and physical factors, escalating in intensity. The search for new pharmacodynamic effects of [1,3,5]-thiadiazine derivatives designated by significant biological activity of these compounds is an essential issue.Aim. To research adaptogenic activity of tetrahydropyrido[2,1-b][1,3,5]thiadiazine derivatives using a modified Porsolt Forced Swim Test.Materials and methods. Four substances from the group of 3-R-8-aryl-6-oxo-3,4,7,8-tetrahydro-2H,6Hpyrido[2,1-b][1,3,5]thiadiazine-9-carbonitriles were selected for the research. Rats were divided into a control group, 5 reference groups (amitriptyline, caffeine, thiotriazolin, thiocetam, ginseng) and 4 experimental groups according to the number of the studied original tetrahydropyrido[2,1-b][1,3,5] thiadiazine derivatives.Results. Intragastric injection of substance 2 for 5 days in the modified forced swim test (forced swimming with freight) increased work capacity and endurance of the rats by 103.42% as opposed to the initial results. The detected adaptogenic activity of this tetrahydropyrido[2,1-b][1,3,5]thiadiazine derivative six times exceeds adaptogenic activity of ginseng and seven times that of amitriptyline. The rats in the control group were active for a bit longer time. Ginseng raised the time of activity by 17% at day 5. Caffeine essentially reduced work capacity and endurance. Amitriptyline showed adaptogenic activity at day 3 of the research (increase by 10.4%). Thiotriazolin also showed adaptogenic activity on day 3 of the research (increase by 30.17%). Thiocetam increased the time of activity by 78.55%. Substance 4 had adaptogenic activity too; it increased the time of activity in aversive conditions by 58.25%, which three times exceeds this parameter for ginseng and four times for amitriptyline. 

Sign in / Sign up

Export Citation Format

Share Document